News & Updates

Show Multimedia Only

Premeal almonds reduce insulin levels, improve glycaemic control in prediabetes

02 Jun 2023 by

Consumption of almonds 30 min before each major meal can help lower postprandial hyperglycaemia (PPHG), insulin, C-peptide levels, and glucagon levels, as well as improve glucose variability and glycaemic control on continuous glucose monitoring system (CGMS) in individuals with prediabetes, a recent study in India has shown.

Premeal almonds reduce insulin levels, improve glycaemic control in prediabetes

02 Jun 2023

Exercise enhances glycaemic control in T1D

02 Jun 2023

Engaging in physical activity appears to improve blood sugar levels in individuals with type 1 diabetes (T1D) who are receiving insulin, as shown in a study.

Exercise enhances glycaemic control in T1D

02 Jun 2023

Mediterranean diet improves health outcomes in poststroke adults

01 Jun 2023 by

Adherence to a Mediterranean diet (MD) provides several health benefits to adults who have had a stroke, suggests a recent study.

Mediterranean diet improves health outcomes in poststroke adults

01 Jun 2023

Original New Drug Application Approvals by US FDA (16-31 May 2023)

01 Jun 2023

New drug applications approved by US FDA as of 16-31 May 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 May 2023)

01 Jun 2023

Intermittent fasting tied to T2D remission

30 May 2023

An intermittent calorie-restricted diet is effective at achieving diabetes remission for at least a year, a recent study has shown.

Intermittent fasting tied to T2D remission

30 May 2023

Nitrate supplements may lower risk of diabetes complications, mortality in hyperglycaemic adults

30 May 2023 by

Increased levels of urinary nitrate appear to contribute to a reduction in the risk of congestive heart failure and diabetic retinopathy and may also lower the risk of death from all causes, cardiovascular disease (CVD), and diabetes in adults with hyperglycaemia, suggests a study.

Nitrate supplements may lower risk of diabetes complications, mortality in hyperglycaemic adults

30 May 2023

Empowerment vs Advocacy: Responsible Stewardship of Patient’s Access to Medicines

29 May 2023 by

Diabetes mellitus (DM) and obesity are two of the most prevalent chronic health conditions worldwide, affecting millions of individuals globally.1,2 As the landscape of diabetes therapy continues to evolve, it is becoming increasingly clear that a one-size-fits-all approach is no longer sufficient. By considering a range of factors beyond just glucose control, healthcare providers can provide more effective, personalized care that results in better outcomes for patients with diabetes.

Empowerment vs Advocacy: Responsible Stewardship of Patient’s Access to Medicines

29 May 2023

GLP1RA added to antidiabetic drugs prevents MACE, HF hospitalization

28 May 2023

Adding glucagon-like peptide-1 receptor agonists (GLP1RA) onto metformin, sulfonylurea, or insulin treatment alone or in combination appears to reduce the incidence of major adverse cardiac events (MACE) and heart failure (HF) hospitalization relative to treatment with dipeptidyl peptidase-4 inhibitors (DPP4i), suggests a study.